Differential distribution of IgA-protease genotypes in mucosal and invasive isolates of Haemophilus influenzae in Sweden

Abstract

BackgroundSeveral different IgA-proteases exist in Haemophilus influenzae. The variants have been suggested to play differential roles in pathogenesis, but there is limited information on their distribution in clinical isolates. The objective of this study was to investigate the distribution of IgA-protease genotypes in H. influenzae and assess the association between IgA-protease genotype and type of clinical infection.MethodsWe performed PCR-screening of the IgA-protease gene variants in two cohorts of clinical H. influenzae. The first cohort consisted of 177 isolates from individuals with respiratory tract infection in January 2010, 2011 and 2012. Information on age, gender and clinical infection was available in this cohort. The second cohort comprised 53 isolates, including NTHi from bloodstream, cerebrospinal fluid (CSF) and urogenital origin as well as encapsulated isolates respresenting all capsule types. We assessed associations between IgA protease genotype and clinical predictors using basic statistical tests of association as well as regression analysis.ResultsThe igaB gene was found in 46% of isolates in the respiratory tract cohort, and no evident trend could be seen during the study years. However, the igaB gene was significantly less common among invasive isolates (19%), p = 0.003 (Fischer’s exact test), even when encapsulated isolates were excluded (21%), p = 0.012. A significantly negative association between bacteraemia and igaB genotype remained after adjusting for covariates. We did not identify a significant association between IgA-protease gene variants and type of respiratory tract infection, but isolates with an igaA2 genotype were overrepresented in pre-school children.ConclusionsThe distribution of IgA-protease gene variants in Swedish H. influenzae highlighted the widespread abundance of the igaB in isolates from cases of respiratory tract infection, but the igaB gene variant was significantly less common in invasive (bloodstream and CSF) isolates of H. influenzae compared with respiratory tract isolates.Electronic supplementary materialThe online version of this article (10.1186/s12879-018-3464-3) contains supplementary material, which is available to authorized users.

Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion

“…Another limitation relates to the reported decrease in the Ig levels after gastrointestinal digestion, while their most effective targeted effect could be in the oral cavity, which could not be assessed in the present study. So, future studies should assess the persistence of the anti-SARS-CoV-2 IgA and IgG in the intestinal content, simulating also the action of the oral enzymatic and microbial metabolism; and explore the action of possible Ig-degrading proteases from the microorganisms that could be present in the infant gut microbiota [ 29 , 30 , 31 , 32 ].…”

Whole-genome analysis of Haemophilus influenzae strains isolated from persons with cystic fibrosis

“…A Swedish study identified this gene in 46% of the strains from the respiratory tract, but in only 19% of the invasive strains. No correlation was found between the type of respiratory tract infection and the presence of the gene [48]. The protease appears to play a role in intracellular survival [49].…”

Nontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance

“…Clinical isolates from the upper respiratory tract (URT) were obtained from nasopharyngeal samples analyzed at the clinical microbiology laboratory at Skåne University Hospital (Lund/Malmö, Sweden). Blood and cerebrospinal fluid isolates used in this study were from a collection of invasive clinical isolates obtained in Sweden between 1997 and 2009 and previously described by Resman et al ( 13 , 37 ). Tonsil specimens were obtained from patients undergoing tonsillectomy with the indications of hypertrophy or recurrent acute tonsillitis (ethics approval number BD46/2007) at Skåne University Hospital ( 38 ).…”